After a somewhat similar pilot program received backlash three years ago, AMC has come up with a new strategy to reward their most spend-y customers with the best seats. By James Hibberd ...
With me on the call today are Joshua B. Cohen and Justin B. Klee, our Co-CEOs; Dr. Camille L. Bedrosian, our Chief Medical ...
CLEVELAND, Ohio — Cleveland strangled a program meant to save children from lead poisoning, binding a $4.9 million state grant for lead abatement so tightly in self-imposed red tape that almost none ...
Bicara Therapeutics (NASDAQ:BCAX) outlined its clinical and development strategy for its lead bifunctional antibody program, FICERA, during a presentation and fireside chat at TD Cowen’s 46th annual ...
Add Yahoo as a preferred source to see more of our stories on Google. The science of movie theater “innovation” in the 2020s has largely been the science of trying to get ever-more blood out of a ...
MEDINA, Ohio -- Leadership Medina County plans to place its flagship LEAD Institute on a brief hiatus beginning this summer, as the organization reimagines the program following the departure of its ...
The science of movie theater “innovation” in the 2020s has largely been the science of trying to get ever-more blood out of a dwindling population of stones. This is all over the concession stand, ...
Today, nearly two-thirds of U.S. workers have access to a 401(k) or similar defined contribution plans, according to ...
Seres Therapeutics (MCRB) lost ~25% in the premarket on Thursday after the company announced plans to pause additional investments for a mid-stage trial designed to test its lead asset SER-155 in ...
AM Best has commented that the Financial Strength Rating of A++ (Superior) and the Long-Term Issuer Credit Rating of "aaa" (Exceptional) of Teachers Insurance and Annuity Association of America (TIAA) ...
If you’re a member of AMC’s paid subscription loyalty programs, you’ll soon get another perk: the opportunity to reserve the best seats in the movie theater before anyone else. On the theater chain’s ...
Just months after laying off a quarter of its workforce to fund a phase 2 study of its bloodstream infection preventive treatment, Seres Therapeutics is pausing that investment and sending more ...